Treatment OutcomeRisk FactorsRetrospective StudiesProspective StudiesFollow-Up StudiesTime FactorsRisk AssessmentPrognosisPredictive Value of TestsPostoperative ComplicationsSeverity of Illness IndexCohort StudiesSensitivity and SpecificityRecurrenceBiological MarkersSurvival AnalysisSurvival RateMultivariate AnalysisNeoplasmsDisease ProgressionIncidenceRiskLogistic ModelsPatient SelectionAge FactorsHospitals, UniversityReproducibility of ResultsDrug Administration ScheduleChi-Square DistributionROC CurveMyocardial InfarctionPrevalenceStrokeAcute DiseaseKaplan-Meier EstimateCross-Sectional StudiesQuestionnairesDrug Therapy, CombinationNeoplasm StagingCase-Control StudiesPractice Guidelines as TopicElectrocardiographyAnticoagulantsHospitalizationPilot ProjectsProportional Hazards ModelsReoperationCardiovascular DiseasesChronic DiseaseUnited StatesDisease-Free SurvivalKidney Failure, ChronicStentsComorbidityCombined Modality TherapyTomography, X-Ray ComputedQuality of LifeRandomized Controlled Trials as TopicRegression AnalysisDeath, Sudden, CardiacNeoplasm Recurrence, LocalDouble-Blind MethodAntineoplastic AgentsRenal DialysisIntensive Care UnitsPreoperative CareStatistics, NonparametricOutcome Assessment (Health Care)Infusions, IntravenousCoronary DiseaseFeasibility StudiesDose-Response Relationship, DrugMaximum Tolerated DoseHospitalsLongitudinal StudiesAntineoplastic Combined Chemotherapy ProtocolsTreatment FailureLength of StaySex FactorsDecision Support TechniquesVenous ThromboembolismMass ScreeningInpatientsBreast NeoplasmsReferral and ConsultationPatient SatisfactionAtrial FibrillationCost-Benefit AnalysisKidney TransplantationRegistriesAmbulatory Care FacilitiesAnalysis of VarianceTumor Markers, BiologicalPrimary Health CareAcademic Medical CentersMagnetic Resonance ImagingImmunosuppressive AgentsKidney DiseasesAspirinPerioperative Care